Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nichi-Iko

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nichi-Iko's Japan sales performance.

GSK and Gilead join global efforts to tackle novel coronavirus

GSK and Gilead join global efforts to tackle novel coronavirus The trials of the drug will take place in Wuhan City, Hubei Province – the epicentre of the outbreak – and will be tested by a team from Beijing-based China-Japan Friendship

Astellas files new application for expanded use of roxadustat in Japan

Astellas files new application for expanded use of roxadustat in Japan Astellas has set its sights on extending the use of roxadustat into Japan, for the treatment of anaemia associated with chronic kidney disease (CKD) in non-dialysis patients. . ... Together with partner FibroGen, Astellas has submitted a supplemental

UK confirms first cases of coronavirus as global concerns mount

UK confirms first cases of coronavirus as global concerns mount There have been 98 cases in upwards of 18 other countries, including the Australia, Canada, France, Finland, Germany, India Japan, the US and Vietnam, and it was almost inevitable that the

It’s Brexit day – now comes the really hard stuff

It’s Brexit day – now comes the really hard stuff She also said that from a life sciences perspective the US, Japan and Australia are among the top countries for those negotiations, and the aim for OLS is to deliver on

J&J gets EMA nod for wider use of Erleada in prostate cancer

J&J gets EMA nod for wider use of Erleada in prostate cancer So far, Nubeqa has been approved in the US, Brazil and Japan, with European filings still pending.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics